SCHEMBL7423733

SCHEMBL7423733

COC(=O)c1ccc2c3c([nH]c2c1)C(=O)CCC3

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.59
HSD17B10 Q99714 3/20 0.59
MAPT P10636 2/20 0.59
ALOX15 P16050 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.59
KIF11 P52732 1/20 0.56
PARP1 P09874 4/20 0.55
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
ALDH1A1 P00352 5/20 0.51
LMNA P02545 3/20 0.51
HPGD P15428 2/20 0.51
POLB P06746 1/20 0.48
RAB9A P51151 1/20 0.48
MAPK1 P28482 2/20 0.48
GAA P10253 1/20 0.48
CSNK2A1 P68400 1/20 0.47
BRD4 O60885 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7466283 0.92 KIF11 (0.58) KDM4EHSD17B10MAPTALOX15SMN1; SMN2
SCHEMBL6070647 0.90 KDM4E (0.72) KDM4EHSD17B10MAPTALOX15SMN1; SMN2
SCHEMBL25234433 0.84 PARP1 (0.61) KDM4EHSD17B10SMN1; SMN2KIF11PARP1
SCHEMBL30414035 0.84 PARP1 (0.61) KDM4EHSD17B10SMN1; SMN2KIF11PARP1
SCHEMBL6449055 0.84 HSD17B10 (0.59) KDM4EHSD17B10MAPTALOX15SMN1; SMN2
SCHEMBL30666090 0.82 PARP1 (0.61) KDM4EHSD17B10SMN1; SMN2KIF11PARP1
SCHEMBL2485234 0.80 MAPT (0.61) KDM4EHSD17B10MAPTSMN1; SMN2KIF11
SCHEMBL6688391 0.79 MAPT (0.60) KDM4EHSD17B10MAPTSMN1; SMN2KIF11
SCHEMBL4109708 0.79 HSD17B10 (0.59) KDM4EHSD17B10MAPTSMN1; SMN2MEN1
SCHEMBL30493571 0.76 PARP1 (0.54) KDM4EHSD17B10SMN1; SMN2KIF11PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed